-
The four departments announced the third batch of anti-cancer drugs and rare disease drugs subject to the value-added tax policy
Time of Update: 2023-01-05
The Ministry of Finance, the General Administration of Customs, the State Administration of Taxation, and the State Medical Products Administration announced in April 2018 that from May 1, 2018, general VAT taxpayers who produce, sell, wholesale, and retail anti-cancer drugs can choose to pay VAT at a rate of 3% according to the simplified method; For imported anti-cancer drugs, import value-added tax will be levied at a reduced rate of 3%.
-
On the same day, there was good news about the launch of 2 new drugs
Time of Update: 2022-12-30
js?cdnversion='+~(-new Date()/36e5)];With the introduction and landing of a series of policy documents to encourage drug innovation and implement priority review and approval, while China's innovative drug industry is booming, the efficiency of review and approval of new drugs at home and abroad is also constantly improving.
-
Daewoong Pharmaceutical Announces U.S. FDA Approval of its IND Application for DWP213388, the First-in-Class Oral, Irreversible, Dual-Acting Antifungal Drug for the Treatment of Autoimmune Diseases
Time of Update: 2022-08-20
, Ltd —DWP213388 is the first-in-class dual-target inhibitor that simultaneously inhibits pathogenic T cells and B cells in various autoimmune diseases SEOUL, South Korea, Aug. 15, 2022 /PRNewswire/ -- Daewoong Pharmaceutical, a publicly listed South Korean company that develops, manufactures and sells pharmaceuticals globally, announced today that the company's Investigational New Drug (IND) application has been approved in the U.
-
The market value has evaporated by 400 billion
Time of Update: 2022-05-12
Some people gloat at misfortune and think that the valuation bubble can be squeezed again, and the 35 times price-earnings ratio is still too high; Some people are downcast, thinking that Hengrui Medicine can no longer afford the name of the carrier of innovative drug research and development; Some people are gearing up, preparing to enter the game at the bottom to enjoy the benefits of the fisherman .
-
14 domestic class 1 new drugs are coming
Time of Update: 2022-03-09
Sales of some ALK inhibitors in Chinese public medical institutions and physical pharmacies in Chinese cities in 2020 (unit: 10,000 yuan) Source: Minet database Innovative Drug One Brother, the first new drug introduced by Hengrui Medicine, known as "Innovative Drug One Brother" Hengrui Medicine, known as Hengrui Medicine, currently has 10 innovative drugs (9 category 1 new drugs) approved for marketing in China, of which anti-tumor drugs account for "half of the country" .
-
Hengrui Medicine's remazolam tosylate for injection received the notice of drug supplement application approval
Time of Update: 2021-10-11
In December 2019, the company's 36mg remazolam tosylate for injection [calculated as remazolam {C21H19BrN4O2}] was approved by the National Food and Drug Administration for routine gastroscopy sedation; it was approved for use in June 2020 Sedation of colonoscopy .
-
Hengrui Pharmaceuticals Ivabradine Hydrogen Sulfate Sustained-Release Tablets Approved for Clinical Trial
Time of Update: 2021-05-02
On April 20, Hengrui Medicine issued an announcement stating that it had recently received approval from the State Food and Drug Administration to issue a "Drug Clinical Trial Approval Notice" for ivabradine hydrogen sulfate sustained-release tablets, and clinical trials will be launched in the near future.
-
The drug administration law was amended and passed: the circumstances of importing drugs from abroad are less serious or can be exempted from punishment
Time of Update: 2021-02-06
Article 124 of the newly amended Drug Administration Law of the People's Republic of China also makes it clear that the sale and use of certain drugs is liable under certain circumstances.
-
Hundreds of billions of diabetes medical market, new members
Time of Update: 2020-11-12
It is understood that Hua-Li Pharmaceuticals is the first biotechnology company to obtain a Pharmaceutical Production License since the implementation of the new Version of the Drug Administration Law on December 1, 2019, which means that Hua-Li Pharmaceuticals can entrust the existing CMO company to carry out drug production after the approval of Dozagliatin into the commercialization stage, which fully guarantees the supply of drugs after the market.
-
Difficult generic drug Xinlitai "hydrochloric acid parositin intestinal dissolved release tablets" was first approved
Time of Update: 2020-09-09
On August 13, Xinlitai Class 4 generic drug "Paroxetine hydrochloric acid intestinal solubility tablets" was approved by the State Drug Administration, successfully won the high-tech difficulty of in
-
There is another class of new drugs declared in the tablets eager to seize the hepatitis drug market
Time of Update: 2020-09-01
On August 18th, the pharmaceutical network announced that a class of 1 new drug PZH2109 capsules declared clinically received CDE acceptance, the drug is mainly used to treat non-alcoholic fatty hepatitis, the United States and China have no same target of the same adaptive drugs approved for market.
-
"Macrophage immunotherapy" CT-0508 treatment of solid tumors: better than traditional cell therapy
Time of Update: 2020-07-30
carISMA Therapeutics, !---- a biopharmaceutical company focused on the development of immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the application for a new research drug (IND) for its main candidate drug, CT-0508, which targets human epidermal growth factor receptor 2 (HER2) inaniated antigen receptor macrophage (CAR-M) therapy.
-
Clinical trials of anti-avian influenza drugs in Thailand are effective
Time of Update: 2020-07-08
Thai medicine officials recently announced that , Thailand's self-developed anti-avian influenza drugs have passed the clinical trial stage The results showed that , the drug to treat H5N1 highly
-
Is the biotech market boom back? These three companies bucked the trend to "break through" the NASDAQ
Time of Update: 2020-06-27
Read: New Crown Pneumonia Can't Stop the Progress of Drug Research and Development!
-
Baxter pre-configured potassium chloride sodium chloride injection stoic sodium chloride injection approved by China's State Drug Administration officially listed
Time of Update: 2020-06-11
according to the relevant literature and reports, about 2.5 million people in China are by drug or drugs each year (adverse reactions prolong the length of hospitalization, and about 192,000 peopl
